Hans Keirstead, UC IrvineThe FDA has lifted a clinical hold that has been in place since 2008 on Menlo Park, CA-based Geron's proposed trial for spinal cord injury. The multi-center phase I trial will be the world's first trial of a therapy based on embryonic stem cells. In a press release, the company's president and … Continue reading Geron to begin stem cell trial for spinal cord injury